VIR
#2066
Vir Biotechnology, Inc. - Common Stock
10.7 9 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.37%
Variación mensual
+23.46%
Variación en los últimos 6 meses
+21.92%
Cambio anual
+80.43%
Cierres anteriores
10.8 3
Open
10.8 3
Mínimo
10.7 4
Máximo
10.8 4
Volumen
215
Financials
- Market Capitalization 1.83 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.48
Relación precio/flujo de caja
5.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2028 |  XNCR Xencor, Inc. - Common Stock | 26.70 USD | +2.46% | -6.81% | +33.77% | +228.01% | 1.99 B USD | ||
| 2051 |  IMCR Immunocore Holdings plc - American Depositary Shares | 35.99 USD | -1.72% | -2.15% | +6.48% | +7.50% | 1.85 B USD | ||
| 2067 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 123.41 USD | -0.42% | +23.69% | +50.76% | +53.15% | 1.82 B USD | ||
| 2070 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.56 USD | -3.64% | -7.33% | -5.60% | +91.72% | 1.81 B USD |